Sunrise Global Exim

Atomoxet 25 mg Tablet (Atomoxetine 25 mg) is a prescription medication primarily used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. It contains atomoxetine, a selective norepinephrine reuptake inhibitor (NRI) that helps improve attention, focus, and impulse control.

Unlike stimulant medications commonly prescribed for ADHD, atomoxetine is a non-stimulant treatment option. It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that plays a key role in attention, behavior regulation, and impulse control. By enhancing norepinephrine activity, Atomoxet helps reduce symptoms such as inattention, hyperactivity, impulsivity, and difficulty concentrating.

The 25 mg tablet is often used as a starting dose or as part of a dose-adjustment plan. The exact dosage depends on the patient’s age, body weight, and response to treatment. Doctors may gradually increase the dose over several weeks to achieve optimal therapeutic effects while minimizing side effects. Atomoxet is usually taken once or twice daily, with or without food, as directed by a healthcare professional.

One of the advantages of atomoxetine is that it has a lower potential for misuse compared to stimulant medications. Because it does not produce the same stimulating effects, it is sometimes preferred for individuals with a history of substance misuse or those who cannot tolerate stimulant therapy.

It is important to understand that Atomoxet does not provide immediate symptom relief. Unlike stimulants, which may show effects within hours, atomoxetine may take 2 to 4 weeks to show noticeable improvement, with full benefits sometimes taking up to 6 to 8 weeks. Consistent daily use is necessary for best results.

Common side effects may include nausea, dry mouth, decreased appetite, dizziness, fatigue, stomach pain, and sleep disturbances. In some individuals, especially children and adolescents, there may be mood changes or irritability. Rarely, atomoxetine may increase blood pressure or heart rate, so regular monitoring may be recommended.

In certain cases, atomoxetine has been associated with an increased risk of suicidal thoughts in children and adolescents, particularly during the early stages of treatment. Caregivers and patients should watch for unusual mood changes, worsening depression, or behavioral changes and seek medical advice if these occur.

Atomoxet should be used cautiously in individuals with heart problems, liver disease, glaucoma, or a history of mental health conditions. It should not be combined with monoamine oxidase inhibitors (MAOIs) or certain other medications without medical supervision.

In conclusion, Atomoxet 25 mg Tablet (Atomoxetine 25 mg) is an effective non-stimulant treatment option for ADHD that works by enhancing norepinephrine activity in the brain. When taken consistently under medical guidance, it can help improve focus, reduce impulsivity, and enhance overall daily functioning.